Literature DB >> 17080246

Studying the overlap between IBS and GERD: a systematic review of the literature.

Igor Nastaskin1, Edgar Mehdikhani, Jeffrey Conklin, Sandy Park, Mark Pimentel.   

Abstract

Evidence points to a significant overlap between irritable bowel syndrome (IBS) and gastroesophageal reflux disease (GERD). In this study, we evaluate this overlap by conducting a systematic review of the literature. Six electronic databases from 1966 through January 2005 were screened by multiple search terms to identify all epidmiological evidence linking IBS and GERD. In addition, AGA meeting abstracts for 2003 and 2004 were also screened. All studies were validated by the authors and data extracted according to predefined criteria. As a separate search strategy, studies evaluating the prevalence of IBS and GERD in the general population were sought. These articles were obtained to compare the prevalence of IBS and GERD in the community to the degree of overlap. The search identified 997 original titles with 15 publications that fulfilled our eligibility criteria. Among the 15 studies, 7 determined the GERD maximum mean prevalence in patients already diagnosed with IBS to be 39.3% and the weighted mean 30.3%. The other 7 studies examined the prevalence of IBS in patients already diagnosed with GERD. The maximum mean prevalence of IBS in subjects with known GERD was 48.8% and the weighted mean 60.5%. Based on the prevalence of IBS (12.1%) and GERD (19.4%) in the community, the rate of IBS in the non-GERD community was calculated to be only 5.1%. There is a strong overlap between GERD and IBS that exceeds the individual presence of each condition. In the absence of GERD, IBS is relatively uncommon.

Entities:  

Mesh:

Year:  2006        PMID: 17080246     DOI: 10.1007/s10620-006-9306-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  47 in total

1.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  Transit through the proximal colon influences stool weight in the irritable bowel syndrome.

Authors:  M Vassallo; M Camilleri; S F Phillips; M L Brown; N J Chapman; G M Thomforde
Journal:  Gastroenterology       Date:  1992-01       Impact factor: 22.682

3.  Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in a Spanish population.

Authors:  M Diaz-Rubio; C Moreno-Elola-Olaso; E Rey; G R Locke; F Rodriguez-Artalejo
Journal:  Aliment Pharmacol Ther       Date:  2004-01-01       Impact factor: 8.171

4.  Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population.

Authors:  T M Kennedy; R H Jones; A P Hungin; H O'flanagan; P Kelly
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

5.  Gastro-oesophageal reflux in the irritable bowel syndrome.

Authors:  H L Smart; D A Nicholson; M Atkinson
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

6.  Irritable bowel syndrome in France: a common, debilitating and costly disorder.

Authors:  Michel Dapoigny; Jérôme Bellanger; Bruno Bonaz; Stanislas Bruley des Varannes; Lionel Bueno; Benoît Coffin; Philippe Ducrotté; Bernard Flourié; Marc Lémann; Anne Lepicard; Olivier Reigneau
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-10       Impact factor: 2.566

7.  Tolerance for rectosigmoid distention in irritable bowel syndrome.

Authors:  W E Whitehead; B Holtkotter; P Enck; R Hoelzl; K D Holmes; J Anthony; H S Shabsin; M M Schuster
Journal:  Gastroenterology       Date:  1990-05       Impact factor: 22.682

8.  The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community.

Authors:  Kok-Ann Gwee; Sharon Wee; Mee-Lian Wong; Damian J C Png
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

9.  Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time.

Authors:  L Agréus; K Svärdsudd; O Nyrén; G Tibblin
Journal:  Gastroenterology       Date:  1995-09       Impact factor: 22.682

10.  Upper gastrointestinal and mental symptoms in the irritable bowel syndrome.

Authors:  J Svedlund; I Sjödin; G Dotevall; R Gillberg
Journal:  Scand J Gastroenterol       Date:  1985-06       Impact factor: 2.423

View more
  34 in total

1.  Proton pump inhibitor therapy does not affect hydrogen production on lactulose breath test in subjects with IBS.

Authors:  David Law; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

Review 2.  Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome.

Authors:  Nicola de Bortoli; Irene Martinucci; Massimo Bellini; Edoardo Savarino; Vincenzo Savarino; Corrado Blandizzi; Santino Marchi
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

3.  Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease.

Authors:  Hubert Mönnikes; Robert C Heading; Holger Schmitt; Hubert Doerfler
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

4.  Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD.

Authors:  Nicola de Bortoli; Leonardo Frazzoni; Edoardo V Savarino; Marzio Frazzoni; Irene Martinucci; Aleksandra Jania; Salvatore Tolone; Michele Scagliarini; Massimo Bellini; Elisa Marabotto; Manuele Furnari; Giorgia Bodini; Salvatore Russo; Lorenzo Bertani; Veronica Natali; Lorenzo Fuccio; Vincenzo Savarino; Corrado Blandizzi; Santino Marchi
Journal:  Am J Gastroenterol       Date:  2016-09-20       Impact factor: 10.864

5.  Analysis of the gastrointestinal symptoms of uninvestigated dyspepsia and irritable bowel syndrome.

Authors:  Kazutoshi Hori; Takayuki Matsumoto; Hiroto Miwa
Journal:  Gut Liver       Date:  2009-09-30       Impact factor: 4.519

6.  Overlap of Erosive and Non-erosive Reflux Diseases With Functional Gastrointestinal Disorders According to Rome III Criteria.

Authors:  Young Wook Noh; Hye-Kyung Jung; Seong-Eun Kim; Sung-Ae Jung
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

7.  Irritable Bowel Syndrome and Co-morbid Gastrointestinal and Extra-gastrointestinal Functional Syndromes.

Authors:  Ami D Sperber; Roy Dekel
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

Review 8.  Gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS)--is it one disease or an overlap of two disorders?

Authors:  Anita Gasiorowska; Choo Hean Poh; Ronnie Fass
Journal:  Dig Dis Sci       Date:  2008-12-10       Impact factor: 3.199

9.  Bacterial overgrowth and irritable bowel syndrome: unifying hypothesis or a spurious consequence of proton pump inhibitors?

Authors:  Brennan M R Spiegel; William D Chey; Lin Chang
Journal:  Am J Gastroenterol       Date:  2008-12       Impact factor: 10.864

10.  Exploring the agreement between diagnostic criteria for IBS in primary care in Greece.

Authors:  Foteini Anastasiou; Ioannis A Mouzas; Joanna Moschandreas; Elias Kouroumalis; Christos Lionis
Journal:  BMC Res Notes       Date:  2008-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.